TapewireFind a company

person · Reporting owner

Menawat Arun Swarup

Disclosed activity across 3 companies

Tapewire entity
33989
SEC CIK
0001685893

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
FIREFLY NEUROSCIENCE, INC.AIFF · Entity 7759DirectorSeptember 25, 2026September 29, 2026
Profound Medical Corp.PROF · Entity 6139Director · CEOMay 15, 2025May 20, 2025
Stereotaxis, Inc.STXS · Entity 6577DirectorJuly 01, 2026July 01, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

FIREFLY NEUROSCIENCE, INC.

Report date September 25, 2026 · Filed September 29, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Deferred Stock UnitsSEC Table II · derivative / convertible securityDirect216,609 Reported balance After 2026-09-25 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-09-25 · Grant · Acquired 126,050 · Balance 216,609

F1: On September 25, 2026, the Reporting Person was granted 126,050 deferred stock units ("DSUs") under the Issuer's 2024 Long-Term Incentive Plan, which vest quarterly over a twelve (12)-month period. Each DSU represents a contingent right to receive one share of the Issuer's common stock.

Filing footnotes · ownership attribution and instrument terms

F1: On September 25, 2026, the Reporting Person was granted 126,050 deferred stock units ("DSUs") under the Issuer's 2024 Long-Term Incentive Plan, which vest quarterly over a twelve (12)-month period. Each DSU represents a contingent right to receive one share of the Issuer's common stock.

Profound Medical Corp.

Report date May 15, 2025 · Filed May 20, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common SharesSEC Table I · non-derivativeDirect587,089 Ending reported balance After 2025-05-16 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2025-05-15 · Purchase · Acquired 10,003 · Balance 575,062

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.30 to $4.35, inclusive. The reporting person undertakes to provide to Profound Medical Corp., any security holder of Profound Medical Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Row 2 · 2025-05-16 · Purchase · Acquired 12,027 · Balance 587,089

F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.70 to $4.78, inclusive. The reporting person undertakes to provide to Profound Medical Corp., any security holder of Profound Medical Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.30 to $4.35, inclusive. The reporting person undertakes to provide to Profound Medical Corp., any security holder of Profound Medical Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.70 to $4.78, inclusive. The reporting person undertakes to provide to Profound Medical Corp., any security holder of Profound Medical Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Stereotaxis, Inc.

Report date July 01, 2026 · Filed July 01, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect1,035,560 Reported balance After 2026-07-01 transaction · row 1
1 source row

Row 1 · 2026-07-01 · Grant · Acquired 43,103 · Balance 1,035,560

F1: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).

Filing footnotes · ownership attribution and instrument terms

F1: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 25, 2026 Filed Sep 29, 2026 20:15 UTC FIREFLY NEUROSCIENCE, INC. AIFF · Entity 7759 GrantDeferred Stock Units · Derivative 126,050 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-104665 · ownership.xml · derivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 216,609

Underlying: Common Stock · 126,050 shares

Expires not disclosed

F1 · derivative.exercise_price: On September 25, 2026, the Reporting Person was granted 126,050 deferred stock units ("DSUs") under the Issuer's 2024 Long-Term Incentive Plan, which vest quarterly over a twelve (12)-month period. Each DSU represents a contingent right to receive one share of the Issuer's common stock.

F1 · derivative.exercise_date: On September 25, 2026, the Reporting Person was granted 126,050 deferred stock units ("DSUs") under the Issuer's 2024 Long-Term Incentive Plan, which vest quarterly over a twelve (12)-month period. Each DSU represents a contingent right to receive one share of the Issuer's common stock.

F1 · derivative.expiration_date: On September 25, 2026, the Reporting Person was granted 126,050 deferred stock units ("DSUs") under the Issuer's 2024 Long-Term Incentive Plan, which vest quarterly over a twelve (12)-month period. Each DSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
July 01, 2026 Filed Jul 1, 2026 20:00 UTC Stereotaxis, Inc. STXS · Entity 6577 GrantCommon Stock 43,103 $0.00 $0.00
Disclosure

SEC source: 0001493152-26-031531 · ownership.xml · nonDerivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,035,560

F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).

Read SEC document
January 02, 2026 Filed Jan 2, 2026 21:15 UTC Stereotaxis, Inc. STXS · Entity 6577 GrantCommon Stock 46,948 $0.00 $0.00
Disclosure

SEC source: 0001493152-26-000120 · ownership.xml · nonDerivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 992,457

F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).

Read SEC document
October 28, 2025 Filed Oct 30, 2025 19:48 UTC FIREFLY NEUROSCIENCE, INC. AIFF · Entity 7759 GrantDeferred Stock Units · Derivative 73,892 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-104097 · ownership.xml · derivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,559

Underlying: Common Stock · 73,892 shares

Expires not disclosed

F1 · derivative.exercise_price: On October 28, 2025, the Reporting Person was granted 73,892 deferred stock units ("DSUs") under the Issuer's 2024 Long-Term Incentive Plan, which vest quarterly over a twelve (12)-month period. Each DSU represents a contingent right to receive one share of the Issuer's common stock.

F1 · derivative.exercise_date: On October 28, 2025, the Reporting Person was granted 73,892 deferred stock units ("DSUs") under the Issuer's 2024 Long-Term Incentive Plan, which vest quarterly over a twelve (12)-month period. Each DSU represents a contingent right to receive one share of the Issuer's common stock.

F1 · derivative.expiration_date: On October 28, 2025, the Reporting Person was granted 73,892 deferred stock units ("DSUs") under the Issuer's 2024 Long-Term Incentive Plan, which vest quarterly over a twelve (12)-month period. Each DSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
July 01, 2025 Filed Jul 3, 2025 20:05 UTC Stereotaxis, Inc. STXS · Entity 6577 GrantCommon Stock 43,668 $0.00 $0.00
Disclosure

SEC source: 0001641172-25-017797 · ownership.xml · nonDerivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 945,509

F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).

Read SEC document
May 19, 2025 Filed May 20, 2025 23:13 UTC FIREFLY NEUROSCIENCE, INC. AIFF · Entity 7759 GrantRestricted Stock Units · Derivative 125,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001437749-25-017885 · rdgdoc.xml · derivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires not disclosed

F1 · kind: On May 19, 2025, the Reporting Person was granted restricted stock units under the Issuer's 2024 Long-Term Incentive Plan ("Plan") for 125,000 shares of common stock, in consideration of the services to be rendered by the Reporting Person to the Company, which shall vest quarterly over a period of three years from May 19, 2025, subject to satisfaction of the Reporting Person's continuous service.

F1 · derivative.exercise_date: On May 19, 2025, the Reporting Person was granted restricted stock units under the Issuer's 2024 Long-Term Incentive Plan ("Plan") for 125,000 shares of common stock, in consideration of the services to be rendered by the Reporting Person to the Company, which shall vest quarterly over a period of three years from May 19, 2025, subject to satisfaction of the Reporting Person's continuous service.

F1 · derivative.expiration_date: On May 19, 2025, the Reporting Person was granted restricted stock units under the Issuer's 2024 Long-Term Incentive Plan ("Plan") for 125,000 shares of common stock, in consideration of the services to be rendered by the Reporting Person to the Company, which shall vest quarterly over a period of three years from May 19, 2025, subject to satisfaction of the Reporting Person's continuous service.

Read SEC document
May 16, 2025 Filed May 20, 2025 17:56 UTC Profound Medical Corp. PROF · Entity 6139 PurchaseCommon Shares 12,027 $4.73 $56,887.71
Disclosure

SEC source: 0001171843-25-003336 · ownership.xml · nonDerivative · entry 2

Menawat Arun Swarup · CIK 0001685893 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 587,089

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.70 to $4.78, inclusive. The reporting person undertakes to provide to Profound Medical Corp., any security holder of Profound Medical Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
May 15, 2025 Filed May 20, 2025 17:56 UTC Profound Medical Corp. PROF · Entity 6139 PurchaseCommon Shares 10,003 $4.33 $43,262.98
Disclosure

SEC source: 0001171843-25-003336 · ownership.xml · nonDerivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 575,062

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.30 to $4.35, inclusive. The reporting person undertakes to provide to Profound Medical Corp., any security holder of Profound Medical Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Read SEC document
March 10, 2025 Filed Mar 12, 2025 22:05 UTC FIREFLY NEUROSCIENCE, INC. AIFF · Entity 7759 GrantDeferred Stock Units · Derivative 16,667 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-007342 · rdgdoc.xml · derivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director · Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 16,667 shares

Expires not disclosed

F1 · derivative.exercise_price: On March 10, 2025, the Reporting Person was granted 16,667 DSUs under the Issuer's 2024 Long-Term Incentive Plan. A total of 8,333 DSUs vested immediately on the date of grant. Another 4,167 DSUs will vest on June 10, 2025, and an additional 4,167 DSUs will vest on September 10, 2025. Each DSU represents a contingent right to receive one share of common stock of the Issuer.

F1 · derivative.exercise_date: On March 10, 2025, the Reporting Person was granted 16,667 DSUs under the Issuer's 2024 Long-Term Incentive Plan. A total of 8,333 DSUs vested immediately on the date of grant. Another 4,167 DSUs will vest on June 10, 2025, and an additional 4,167 DSUs will vest on September 10, 2025. Each DSU represents a contingent right to receive one share of common stock of the Issuer.

F1 · derivative.expiration_date: On March 10, 2025, the Reporting Person was granted 16,667 DSUs under the Issuer's 2024 Long-Term Incentive Plan. A total of 8,333 DSUs vested immediately on the date of grant. Another 4,167 DSUs will vest on June 10, 2025, and an additional 4,167 DSUs will vest on September 10, 2025. Each DSU represents a contingent right to receive one share of common stock of the Issuer.

Read SEC document
January 02, 2025 Filed Jan 2, 2025 22:30 UTC Stereotaxis, Inc. STXS · Entity 6577 GrantCommon Stock 56,497 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-000100 · ownership.xml · nonDerivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 901,841

F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).

Read SEC document
July 01, 2024 Filed Jul 1, 2024 21:30 UTC Stereotaxis, Inc. STXS · Entity 6577 GrantCommon Stock 53,475 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-025866 · ownership.xml · nonDerivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 845,344

F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).

Read SEC document
January 02, 2024 Filed Jan 2, 2024 22:00 UTC Stereotaxis, Inc. STXS · Entity 6577 GrantCommon Stock 64,935 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-000114 · ownership.xml · nonDerivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 791,869

F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).

Read SEC document
July 03, 2023 Filed Jul 3, 2023 20:05 UTC Stereotaxis, Inc. STXS · Entity 6577 GrantCommon Stock 47,619 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-023295 · ownership.xml · nonDerivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 726,934

F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).

Read SEC document
January 03, 2023 Filed Jan 3, 2023 21:10 UTC Stereotaxis, Inc. STXS · Entity 6577 GrantCommon Stock 54,054 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-000121 · ownership.xml · nonDerivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 679,315

F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).

Read SEC document
July 01, 2022 Filed Jul 1, 2022 20:00 UTC Stereotaxis, Inc. STXS · Entity 6577 GrantCommon Stock 15,527 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-018356 · ownership.xml · nonDerivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 625,261

F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).

Read SEC document
January 04, 2022 Filed Jan 4, 2022 21:05 UTC Stereotaxis, Inc. STXS · Entity 6577 GrantCommon Stock 10,449 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-000296 · ownership.xml · nonDerivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 609,734

F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).

Read SEC document
July 01, 2021 Filed Jul 6, 2021 15:12 UTC Stereotaxis, Inc. STXS · Entity 6577 GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-21-016172 · ownership.xml · nonDerivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 599,285

F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).

Read SEC document
January 04, 2021 Filed Jan 6, 2021 16:32 UTC Stereotaxis, Inc. STXS · Entity 6577 GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-21-000294 · ownership.xml · nonDerivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 569,285

F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).

Read SEC document
July 01, 2020 Filed Jul 6, 2020 21:18 UTC Stereotaxis, Inc. STXS · Entity 6577 GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-20-012665 · ownership.xml · nonDerivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 539,285

F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:10 UTC Stereotaxis, Inc. STXS · Entity 6577 GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-20-000220 · ownership.xml · nonDerivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 509,285

F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).

Read SEC document
July 01, 2019 Filed Jul 1, 2019 10:15 UTC Stereotaxis, Inc. STXS · Entity 6577 GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-19-009943 · ownership.xml · nonDerivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 479,285

F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).

Read SEC document
January 02, 2019 Filed Jan 3, 2019 18:07 UTC Stereotaxis, Inc. STXS · Entity 6577 GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-19-000102 · ownership.xml · nonDerivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 449,285

F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control of the Company (as defined in the award documents).

Read SEC document
July 02, 2018 Filed Jul 2, 2018 20:16 UTC Stereotaxis, Inc. STXS · Entity 6577 GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001289340-18-000067 · edgar.xml · nonDerivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 419,285

F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control of the Company (as defined in the award documents).

Read SEC document
March 01, 2018 Filed Mar 5, 2018 23:03 UTC Stereotaxis, Inc. STXS · Entity 6577 OtherCommon Stock Warrant (right to buy) · Derivative 153,846 $0.00 Strike: $0.28 $0.00
Disclosure

SEC source: 0001289340-18-000043 · edgar.xml · derivative · entry 4

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 153,846 shares

Expires 2021-09-29

Read SEC document
March 01, 2018 Filed Mar 5, 2018 23:03 UTC Stereotaxis, Inc. STXS · Entity 6577 GrantCommon Stock Warrant (right to buy) · Derivative 153,846 Not disclosed Strike: $0.28 Not disclosed
Disclosure

SEC source: 0001289340-18-000043 · edgar.xml · derivative · entry 3

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,846

Underlying: Common Stock · 153,846 shares

Expires 2021-09-29

F1 · date: On February 28, 2018, the issuer and certain holders of outstanding warrants issued pursuant to the Stock Purchase Agreement dated September 26, 2016, including the reporting person, entered into an amendment to the warrants. The amendment provided that the exercise price of the warrants would be reduced for a limited period of time, provided that at least $6 million of warrants was exercised during the limited period. This condition was satisfied on March 1, 2018.

F2 · price: The transactions reported in the first two lines of Table II above report the amendment of the warrant to temporarily reduce the exercise price from $0.70 per share to $0.28 per share. The amendment is reported as the disposition of the old warrant and the acquisition of a new one. The amendment to the warrant was approved by a transaction committee consisting solely of independent directors for purposes of Rules 16b-3(d) and (e).

Read SEC document
March 01, 2018 Filed Mar 5, 2018 23:03 UTC Stereotaxis, Inc. STXS · Entity 6577 Disposition to issuerCommon Stock Warrant (right to buy) · Derivative 153,846 Not disclosed Strike: $0.70 Not disclosed
Disclosure

SEC source: 0001289340-18-000043 · edgar.xml · derivative · entry 2

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 153,846 shares

Expires 2021-09-29

F1 · date: On February 28, 2018, the issuer and certain holders of outstanding warrants issued pursuant to the Stock Purchase Agreement dated September 26, 2016, including the reporting person, entered into an amendment to the warrants. The amendment provided that the exercise price of the warrants would be reduced for a limited period of time, provided that at least $6 million of warrants was exercised during the limited period. This condition was satisfied on March 1, 2018.

F2 · price: The transactions reported in the first two lines of Table II above report the amendment of the warrant to temporarily reduce the exercise price from $0.70 per share to $0.28 per share. The amendment is reported as the disposition of the old warrant and the acquisition of a new one. The amendment to the warrant was approved by a transaction committee consisting solely of independent directors for purposes of Rules 16b-3(d) and (e).

Read SEC document
March 01, 2018 Filed Mar 5, 2018 23:03 UTC Stereotaxis, Inc. STXS · Entity 6577 OtherCommon Stock 153,846 $0.28 $43,076.88
Disclosure

SEC source: 0001289340-18-000043 · edgar.xml · nonDerivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 389,285

Read SEC document
January 02, 2018 Filed Jan 2, 2018 19:22 UTC Stereotaxis, Inc. STXS · Entity 6577 GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001289340-18-000016 · edgar.xml · nonDerivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 235,439

F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control of the Company (as defined in the award documents).

Read SEC document
July 03, 2017 Filed Jul 6, 2017 20:07 UTC Stereotaxis, Inc. STXS · Entity 6577 GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0000950138-17-000534 · edgar.xml · nonDerivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 205,439

F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control of the Company (as defined in the award documents).

Read SEC document
December 02, 2016 Filed Dec 6, 2016 21:07 UTC Stereotaxis, Inc. STXS · Entity 6577 ConversionSeries A Convertible Preferred Stock · Derivative 100 $0.00 Strike: $0.65 $0.00
Disclosure

SEC source: 0001289340-16-000157 · edgar.xml · derivative · entry 2

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 155,439 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Initial conversion/exericise price. The conversion/exercise price is subject to adjustment.

F2 · derivative.exercise_date: The Series A convertible preferred stock is convertible at the election of the holder at anytime and has no expiration date.

F2 · derivative.expiration_date: The Series A convertible preferred stock is convertible at the election of the holder at anytime and has no expiration date.

F3 · derivative.underlying_shares: The number of shares of common stock issued upon conversion was calculated based on the stated value of the convertible preferred stock of $1,000 per share increased by the amount of dividends at a rate of 6% per annum, which was cumulative and accrued daily from the date of issuance on the $1,000 stated value and the conversion price of $.65 per share.

Read SEC document
December 02, 2016 Filed Dec 6, 2016 21:07 UTC Stereotaxis, Inc. STXS · Entity 6577 ConversionCommon Stock 155,439 $0.65 $101,035.35
Disclosure

SEC source: 0001289340-16-000157 · edgar.xml · nonDerivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 175,439

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: The number of shares of common stock issued upon conversion was calculated based on the stated value of the convertible preferred stock of $1,000 per share increased by the amount of dividends at a rate of 6% per annum, which was cumulative and accrued daily from the date of issuance on the $1,000 stated value and the conversion price of $.65 per share.

Read SEC document
September 29, 2016 Filed Oct 3, 2016 21:39 UTC Stereotaxis, Inc. STXS · Entity 6577 OtherCommon Stock Warrant (right to buy) · Derivative 153,846 $0.00 Strike: $0.70 $0.00
Disclosure

SEC source: 0001289340-16-000153 · edgar.xml · derivative · entry 3

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,846

Underlying: Common Stock · 153,846 shares

Expires 2021-09-29

F2 · derivative.exercise_price: Initial conversion/exercise price. The conversion/exercise price is subject to adjustment.

F5 · kind: The warrants were acquired in connection with the purchase of Series A convertible preferred stock.

F6 · derivative.underlying_shares: The number of shares is based on the initial exercise price of $.70. The exercise price is subject to adjustment.

Read SEC document
September 29, 2016 Filed Oct 3, 2016 21:39 UTC Stereotaxis, Inc. STXS · Entity 6577 PurchaseSeries A Convertible Preferred Stock · Derivative 100 $1,000.00 Strike: $0.65 $100,000.00
Disclosure

SEC source: 0001289340-16-000153 · edgar.xml · derivative · entry 2

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100

Underlying: Common Stock · 153,846 shares

Expires not disclosed

F2 · derivative.exercise_price: Initial conversion/exercise price. The conversion/exercise price is subject to adjustment.

F3 · derivative.exercise_date: The Series A convertible preferred stock is convertible at the election of the holder at any time and has no expiration date.

F3 · derivative.expiration_date: The Series A convertible preferred stock is convertible at the election of the holder at any time and has no expiration date.

F4 · derivative.underlying_shares: The number of shares is based on the initial conversion price of $.65. The conversion price is subject to adjustment. For purposes of determining the number of shares of common stock upon conversion, the value of the convertible preferred stock will be increased by the amount of dividends at a rate of 6% per annum, which will be cumulative and accrue daily from the date of issuance on the $1,000 stated value.

Read SEC document
September 29, 2016 Filed Oct 3, 2016 21:39 UTC Stereotaxis, Inc. STXS · Entity 6577 GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001289340-16-000153 · edgar.xml · nonDerivative · entry 1

Menawat Arun Swarup · CIK 0001685893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest over a period of two (2) years with 50% vesting on the first anniversary of the date of the grant and the remaining 50% vesting on the second anniversary of the date of the grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.